Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA transcription factors are a diverse group of regulatory proteins that control gene expression by binding in a sequence-specific manner to regulatory DNA regions such as promoters and enhancers. They play central roles in determining cell fate, proliferation, apoptosis, and are essential in both development and disease. Transcription factors are classified by their DNA-binding domains, such as zinc finger, helix-turn-helix, leucine zipper, and basic helix-loop-helix domains, and can function alone or in complexes to facilitate or inhibit RNA polymerase activity. Their dysregulation is implicated in numerous diseases, making them important—but therapeutically challenging—targets in drug development.
Inhibition or activation of transcription factor binding to DNA Modulation of transcription factor activity by interfering with dimerization, nuclear localization, or post-translational modifications
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA transcription factor (TF).